Tuesday 30 August - Hot Line - Preventive Strategies II
Andreas Goette: ENSURE-AF study: Edoxaban for cardioversion of atrial fibrillation (Abstract 5715)
Stuart J Connolly: ANNEXA-4 - Andexanet alfa for reversal of Factor Xa inhibitors in patients with acute major bleeding (Abstract 5718)
Marc Rodger: REVERSE II - Multi-national validation of the men continue and HERDOO2 rule to identify low risk unprovoked venous thromboembolism patients who can discontinue anticoagulants (Abstract 5721)
Tom Van der Hulle: YEARS - Safety and efficiency of a simplified diagnostic management algorithm for 3500 patients with clinically suspected acute pulmonary embolism (Abstract 5727)